LENSAR Framtida tillväxt
Future kriterier kontrolleras 2/6
LENSAR s intäkter förväntas minska med 74.3% per år medan dess årliga intäkter förväntas växa med 20.8% per år. EPS förväntas falla med 88.1% per år.
Viktig information
-74.3%
Tillväxttakt i vinsten
-88.07%
Tillväxttakt för EPS
| Medical Equipment vinsttillväxt | 17.3% |
| Intäkternas tillväxttakt | 20.8% |
| Framtida avkastning på eget kapital | n/a |
| Bevakning av analytiker | Low |
| Senast uppdaterad | 13 Aug 2026 |
Senaste uppdateringarna om framtida tillväxt
Recent updates
Uppdatering av berättelse • Aug 13
LNSR: Higher Market Share Expectations And Margin Outlook Will Drive Repricing
Analysts raised their price target on LENSAR from $10 to $13, a $3 increase that they attribute to higher long term market share expectations for the ALLY system and updated revenue and earnings estimates for 2026 and 2027. What’s in the News for LENSAR LENSAR was removed from several Russell indices, including the Russell 2000 Index, Russell 3000 Index, Russell 2500 Index, Russell Small Cap Completeness Index, and related growth benchmarks.
Uppdatering av berättelse • Jul 06
LNSR: Index Shifts And Margin Reset Will Support Future Upside
Analysts have reset their fair value price target for LENSAR from $15.00 to $10.00, reflecting updated assumptions around revenue growth, profit margins, the discount rate, and a higher projected future P/E multiple. What’s in the News for LENSAR LENSAR, Inc.Uppdatering av berättelse • Jun 22
LNSR: Recent Upgrade And Margin Outlook Will Drive Repricing Potential
Analysts have maintained their $8.50 price target on LENSAR, citing a modestly lower discount rate and slightly adjusted long term margin and P/E assumptions following a recent upgrade in Street research coverage. What's in the News On April 10, 2026, LENSAR reported that Chief Financial Officer Thomas R.Uppdatering av berättelse • Jun 03
LNSR: Post Deal Selloff Will Set Up Margin Led Repricing Potential
Analysts have lifted their price target on LENSAR to $10, citing stronger profit margin expectations, a lower assumed discount rate, and a reduced future P/E, even as projected revenue growth is now more conservative. Analyst Commentary Bullish Takeaways Bullish analysts highlight the $10 price target as reflecting confidence that LENSAR's expected profit margins can support a higher valuation multiple than previously assumed.Uppdatering av berättelse • May 04
LNSR: Buy Thesis Will Rebuild Around Post Deal Selloff And Adoption Reacceleration
Analysts have nudged their price target on LENSAR stock to $8.50, with recent upgrades to Buy and renewed confidence around the ALLY System adoption story cited as key reasons for the updated view. Analyst Commentary Recent research has focused on how the ALLY System adoption story and the fallout from the halted Alcon acquisition are shaping expectations for LENSAR’s execution and valuation.Uppdatering av berättelse • Apr 19
LNSR: Buy Thesis Rebuilds Around Post Deal Selloff And Adoption Reacceleration
Analysts have raised their price targets on LENSAR shares to $10, citing renewed optimism around ALLY System adoption and viewing the post acquisition setback selloff as a second chance for investors. Analyst Commentary Bullish Takeaways Bullish analysts point to a $10 price target as a simple yardstick for how they frame upside potential if ALLY System adoption trends seen before the Alcon deal announcement can be re established.
Ny berättelse • Apr 17
Cataract Procedure Bundling Will Pressure Margins Yet Recurring Revenue Should Support Gradual Recovery
Catalysts About LENSAR LENSAR develops and commercializes robotic femtosecond laser systems for cataract surgery, with a focus on its ALLY Robotic Laser Cataract System. What are the underlying business or industry changes driving this perspective?Uppdatering av berättelse • Apr 03
LNSR: Buy Rating Resets Around Post Deal Selloff And Execution Rebuild
Analysts have trimmed their price target for LENSAR to $8.50 from $12.50, reflecting updated views on revenue growth, profitability and a lower future P/E, while also pointing to recent upgrades that highlight renewed interest in the stock following the failed Alcon acquisition. Analyst Commentary Recent Street research has focused on the reset expectations for LENSAR following the failed Alcon transaction, as well as the potential runway for the company’s ALLY System.Ny berättelse • Mar 31
Recurring Cataract Procedure Revenue And Machine Learning Will Transform This Undervalued Medical Device Story
Catalysts About LENSAR LENSAR develops and commercializes the ALLY Robotic Laser Cataract System for laser assisted cataract surgery. What are the underlying business or industry changes driving this perspective?Uppdatering av berättelse • Mar 19
LNSR: Buy Rating And Post Deal Reset Will Drive Future Reassessment
Analysts have trimmed their fair value estimate for LENSAR from $15.00 to $12.50, pointing to revised assumptions around discount rates, margins, and future P/E, alongside a BTIG upgrade to Buy that highlights past ALLY System adoption and the recent post acquisition selloff as a potential second chance for investors to reassess the story. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the cut in fair value to $12.50 still sits above the current $10 price target.Ny berättelse • May 10
Global System Placements Will Improve Operating Room Efficiency
Strong system placements and contract pipelines in international markets enhance potential for sustained revenue growth and competitive advantage.Analysartikel • Jan 28
Even With A 28% Surge, Cautious Investors Are Not Rewarding LENSAR, Inc.'s (NASDAQ:LNSR) Performance Completely
Despite an already strong run, LENSAR, Inc. ( NASDAQ:LNSR ) shares have been powering on, with a gain of 28% in the...Analysartikel • Dec 24
We're Hopeful That LENSAR (NASDAQ:LNSR) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, LENSAR...Analysartikel • Oct 24
Market Might Still Lack Some Conviction On LENSAR, Inc. (NASDAQ:LNSR) Even After 28% Share Price Boost
LENSAR, Inc. ( NASDAQ:LNSR ) shareholders would be excited to see that the share price has had a great month, posting a...Analysartikel • Sep 12
LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Analysartikel • Jul 16
LENSAR, Inc. (NASDAQ:LNSR) Doing What It Can To Lift Shares
With a price-to-sales (or "P/S") ratio of 1.3x LENSAR, Inc. ( NASDAQ:LNSR ) may be sending bullish signals at the...Analysartikel • May 01
Here's Why Shareholders May Want To Be Cautious With Increasing LENSAR, Inc.'s (NASDAQ:LNSR) CEO Pay Packet
Key Insights LENSAR to hold its Annual General Meeting on 7th of May Salary of US$541.1k is part of CEO Nick Curtis's...Analysartikel • Feb 22
LENSAR, Inc.'s (NASDAQ:LNSR) Shares Leap 33% Yet They're Still Not Telling The Full Story
LENSAR, Inc. ( NASDAQ:LNSR ) shares have continued their recent momentum with a 33% gain in the last month alone...Analysartikel • Jan 24
Here's Why We're Watching LENSAR's (NASDAQ:LNSR) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...Analysartikel • Dec 20
Not Many Are Piling Into LENSAR, Inc. (NASDAQ:LNSR) Just Yet
LENSAR, Inc.'s ( NASDAQ:LNSR ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a strong buy right now...Analysartikel • Oct 21
Here's Why We're A Bit Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, although...Analysartikel • Sep 13
Investors Continue Waiting On Sidelines For LENSAR, Inc. (NASDAQ:LNSR)
LENSAR, Inc.'s ( NASDAQ:LNSR ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right now...Analysartikel • Mar 21
This Broker Just Slashed Their LENSAR, Inc. (NASDAQ:LNSR) Earnings Forecasts
One thing we could say about the covering analyst on LENSAR, Inc. ( NASDAQ:LNSR ) - they aren't optimistic, having just...Analysartikel • Mar 18
Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...Analysartikel • Nov 01
Here's Why We're Not Too Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...Prognoser för vinst- och omsättningstillväxt
| Datum | Intäkter | Intäkter | Fritt kassaflöde | Kassaflöde från rörelsen | Genomsnittligt Antal analytiker |
|---|---|---|---|---|---|
| 12/31/2028 | 102 | 9 | N/A | N/A | 1 |
| 12/31/2027 | 74 | 2 | N/A | N/A | 2 |
| 12/31/2026 | 61 | 39 | N/A | N/A | 2 |
| 6/30/2026 | 60 | 35 | N/A | N/A | N/A |
| 3/31/2026 | 58 | 29 | -12 | -12 | N/A |
| 12/31/2025 | 58 | -34 | -15 | -15 | N/A |
| 9/30/2025 | 59 | -52 | -12 | -12 | N/A |
| 6/30/2025 | 58 | -49 | -5 | -5 | N/A |
| 3/31/2025 | 57 | -57 | -4 | -4 | N/A |
| 12/31/2024 | 53 | -31 | -2 | -2 | N/A |
| 9/30/2024 | 49 | -17 | -7 | -6 | N/A |
| 6/30/2024 | 45 | -14 | -10 | -10 | N/A |
| 3/31/2024 | 45 | -12 | -9 | -8 | N/A |
| 12/31/2023 | 42 | -14 | -10 | -10 | N/A |
| 9/30/2023 | 40 | -13 | -14 | -14 | N/A |
| 6/30/2023 | 38 | -18 | -19 | -18 | N/A |
| 3/31/2023 | 34 | -18 | -19 | -19 | N/A |
| 12/31/2022 | 35 | -20 | -15 | -15 | N/A |
| 9/30/2022 | 36 | -21 | -11 | -11 | N/A |
| 6/30/2022 | 37 | -23 | -9 | -8 | N/A |
| 3/31/2022 | 37 | -21 | -7 | -7 | N/A |
| 12/31/2021 | 34 | -20 | -9 | -9 | N/A |
| 9/30/2021 | 32 | -23 | -11 | -10 | N/A |
| 6/30/2021 | 30 | -21 | -8 | -8 | N/A |
| 3/31/2021 | 28 | -21 | -12 | -12 | N/A |
| 12/31/2020 | 26 | -20 | -14 | -14 | N/A |
| 9/30/2020 | 27 | -15 | -19 | -19 | N/A |
| 6/30/2020 | 27 | -16 | -22 | -21 | N/A |
| 3/31/2020 | 29 | -15 | N/A | -17 | N/A |
| 12/31/2019 | 31 | -15 | N/A | -13 | N/A |
| 12/31/2018 | 24 | -14 | N/A | -2 | N/A |
Analytiker Framtid Tillväxt Prognoser
Intäkter kontra sparande: LNSR s intäkter förväntas minska under de kommande 3 åren ( -74.3% per år).
Resultat vs marknad: LNSR s intäkter förväntas minska under de kommande 3 åren ( -74.3% per år).
Höga tillväxtresultat: LNSR s intäkter förväntas minska under de kommande 3 åren.
Intäkt vs marknad: LNSR s intäkter ( 20.8% per år) förväntas växa snabbare än US marknaden ( 12.9% per år).
Hög tillväxtintäkter: LNSR s intäkter ( 20.8% per år) förutspås växa snabbare än 20% per år.
Tillväxtprognoser för vinst per aktie
Framtida avkastning på eget kapital
Framtida ROE: Otillräcklig data för att avgöra om LNSR s avkastning på eget kapital förväntas bli hög om tre år
Upptäck tillväxtföretag
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/08/14 09:28 |
| Aktiekurs vid dagens slut | 2026/08/14 00:00 |
| Intäkter | 2026/06/30 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
LENSAR, Inc. bevakas av 3 analytiker. 2 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| Michael Gorman | BTIG |
| Frank Takkinen | Lake Street Capital Markets, LLC |
| Richard Newitter | Leerink Partners LLC |